We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
ThalesNano Announces the Launch of H-Cube Midi™
Product News

ThalesNano Announces the Launch of H-Cube Midi™

ThalesNano Announces the Launch of H-Cube Midi™
Product News

ThalesNano Announces the Launch of H-Cube Midi™


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "ThalesNano Announces the Launch of H-Cube Midi™"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

ThalesNano Inc. announced that it has launched the latest of its Cube™ flow reactor series, H-Cube Midi™. This product is now commercially available and validated with several important chemistry applications.

The H-Cube Midi™ is designed to fulfill the requirements of process scale flow hydrogenation. Based upon the current H-Cube®technology platform, the H-Cube Midi™ is designed to increase the capacity of the present H-Cube®up to kg quantities per day without compromising efficiency and safety.

Dr. Laszlo Urge, CEO of ThalesNano commented: "H-Cube Midi™ was designed in response to increasing customer needs to be able to scale up reactions optimized on H-Cube®. Several pharmaceutical companies have adopted H-Cube®as the first choice for hydrogenation in discovery.

As compounds move from discovery to development, there is a need to increase the scale up to kg levels as fast as possible. The H-Cube Midi™ allows the optimization and transition from mg scale to kg levels to be performed within a day. The increase in productivity and the savings in cost and time are expected to be significant for those R&D organizations who have adopted this technology."

"The launch of this new product underlines that we are executing a complex strategy and building a product portfolio in the flow chemistry area.

Our product development strategy is designed to provide integrated continuous flow solutions from discovery to full scale production and could help solve some of the bottlenecks in the pharmaceutical and chemical industries" stated Dr. Ferenc Darvas, President and Chairman at ThalesNano.

Advertisement